February 22, 2015 | NYU Langone Medical Center and the Technion-Israel Institute of Technology announced that they received a $9 million gift from Laura and Isaac Perlmutter to fund two, major joint cancer research endeavors. The institutions believe that there is potentially far-reaching impact for the research projects in question to advance cancer research. The first $3 million grant will finance six cancer-focused research projects conducted by researchers at NYU Langone and the Technion. The remaining $6 million will be used to establish a state-of-the-art research facility on Technion’s campus in Israel that will support these and other research projects– and which will have a principal focus on the emerging field of cancer metabolomics. NYU Langone is a world-renowned leader in the investigation and treatment of cancer. The Technion is one of Israel’s leading academic and research centers and a top-ranked science and technology global research university.